查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1617856

注射给药市场：按设备类型、可用​​性、治疗应用和最终用户划分 - 2025-2030 年全球预测

Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Therapeutic Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

注射给药市场2023年估值为9,722.5亿美元，预计2024年将达到14,206亿美元，复合年增长率为7.58%，到2030年将达到16,217亿美元，预计将达到1,000万美元。

注射给药是指透过注射的方式将药物注入体内，为口服或其他非侵入途径无法有效代谢的药物的递送提供了重要手段。注射给药的需求是因为其治疗效果快、剂量准确，以及慢性病管理、免疫接种和紧急情况下的必要性。典型应用包括癌症、糖尿病、心血管疾病和疫苗，最终用途包括医疗机构、居家照护环境和专科诊所。该市场的成长是由生技药品的进步、慢性病盛行率的增加以及智慧型设备和自行注射设备等技术创新所推动的。此外，生技药品和生物相似药的兴起增加了对新型有效注射给药系统的需求。

主要市场统计
基准年[2023] 9722.5亿美元
预计年份 [2024] 1,420,060 百万美元
预测年份 [2030] 1,621,710 百万美元
复合年增长率（%） 7.58%

然而，重大挑战仍然存在，包括高昂的开发成本、严格的法律规范、患者依从性问题以及与针头系统相关的安全风险。机会在于开发利用无针技术和物联网来提高依从性和患者管理的连网型设备。预填充式注射器和自动注射器的普及、穿戴式註射器的进步以及数位健康技术的整合预计将推动市场扩张。为了利用这些机会，公司应该投资以患者为中心的设计研发，并与科技公司合作以增强药物输送体验。产业也应专注于克服可能抑製成长的限制，例如製造复杂性和生物有效性问题。此外，创新领域包括微针贴片、生物分解性聚合物和缓释性输送系统的开发，预计将颠覆传统模式。该市场的特点是其动态性，越来越多地转向个人化医疗，并且需要不断监控监管和技术环境以保持竞争力。

市场动态：揭示快速发展的注射给药市场的关键市场洞察

供需的动态交互作用正在改变注射给药市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 针技术的技术进步
    • 慢性病增加
    • 世界老年人口显着成长
  • 市场限制因素
    • 开发注射给药解决方案的成本高昂
  • 市场机会
    • 智慧注射装置的开发
    • 对自我管理设备的需求增加
  • 市场挑战
    • 患者对针头的依从性差且缺乏注射设备使用训练

波特五力：驾驭注射给药市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解注射给药市场的外部影响

外部宏观环境因素在塑造注射给药市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解注射给药市场的竞争格局

对注射给药市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵注射给药市场供应商绩效评估

FPNV 定位矩阵是评估注射给药市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了注射给药市场的成功之路

注射给药市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 针技术的技术进步
      • 慢性病增加
      • 世界各地的老年人口正在迅速增加。
    • 抑制因素
      • 注射给药解决方案的开发成本较高
    • 机会
      • 智慧注射装置的开发
      • 对自我管理设备的需求增加
    • 任务
      • 患者针头依从性差且缺乏注射设备使用训练
  • 市场区隔分析
    • 设备类型：由于易于使用，自行注射设备越来越受青睐
    • 最终用户：考虑安全性和便携性，考虑在居家照护环境中的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依设备类型分類的注射给药市场

  • 传统注射装置
  • 自註射器
    • 自动注射器
    • 无针注射器
    • 笔式註射器
    • 穿戴式註射器

第七章註射给药市场：依可用性

  • 一次性的
  • 可重复使用的

第八章依治疗应用分類的注射给药市场

  • 自体免疫疾病
  • 癌症
  • 慢性病
  • 荷尔蒙疗法
  • 感染疾病

第九章註射给药市场：依最终用户分类

  • 家庭护理设置
  • 医院/诊所

第十章美洲注射给药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太注射给药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲注射给药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 斯蒂瓦那托集团推出 Vertiva，一种创新的内部给药系统，旨在改善患者照护和永续性
    • Altaviz 推出 AltaVISC，一种创新的自动注射器平台，可提高药物输送效率
    • UDENYCA 自动注射器的推出提高了患者的可及性和管理效率
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Antares Pharma by Halozyme Therapeutics
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Emperra GmbH
  • Enable Injections LLC
  • F. Hoffman-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PlC
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Ravimed Sp. z oo
  • Recipharm AB
  • Sanofi SA
  • SiO2 Medical Products
  • Stevanato Group
  • Tandem Diabetes Care
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
Product Code: MRR-CB04E0565350

The Injectable Drug Delivery Market was valued at USD 972.25 billion in 2023, expected to reach USD 1,042.06 billion in 2024, and is projected to grow at a CAGR of 7.58%, to USD 1,621.71 billion by 2030.

Injectable drug delivery refers to the administration of medications into the body through injections, offering a critical avenue for delivering drugs that cannot be effectively metabolized through oral or other non-invasive routes. The necessity for injectable drug delivery stems from its ability to provide rapid onset of therapeutic action, precision in dosage administration, and is vital for managing chronic diseases, vaccinations, and emergency situations. Key applications span a wide range including oncology, diabetes, cardiovascular diseases, and vaccines, with end-use diverging across healthcare facilities, homecare settings, and specialized clinics. Growth in this market is propelled by advancements in biologics, increasing prevalence of chronic diseases, and technological innovations such as smart and self-injecting devices. Additionally, the rise of biologics and biosimilars is increasing demand for novel and effective injectable delivery systems.

KEY MARKET STATISTICS
Base Year [2023] USD 972.25 billion
Estimated Year [2024] USD 1,042.06 billion
Forecast Year [2030] USD 1,621.71 billion
CAGR (%) 7.58%

However, substantial challenges persist, including the high cost of development, stringent regulatory frameworks, and issues around patient compliance and safety risks associated with needle-based systems. Opportunities lie in the development of needle-free technologies and connected devices powered by IoT that improve adherence and patient management. Market expansion is likely influenced by the increasing popularity of pre-filled syringes and auto-injectors, advancements in wearable injectors, and the integration of digital health technologies. To capitalize on these opportunities, companies should invest in R&D for patient-centric designs and collaborate with technology firms to enhance the drug delivery experience. Industries should also focus on overcoming limitations such as manufacturing complexities and bioavailability issues that may impede growth. Furthermore, innovation areas include the development of microneedle patches, biodegradable polymers, and sustained-release delivery systems that promise to disrupt traditional paradigms. The market is characterized by its dynamic nature, with an increasing shift towards personalized medicine, which mandates constant surveillance of regulatory and technological landscapes to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Injectable Drug Delivery Market

The Injectable Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Technological advancements in needle technology
    • Increasing prevalence of chronic diseases
    • Significant rise in elderly population worldwide
  • Market Restraints
    • High development costs of injectable drug delivery solutions
  • Market Opportunities
    • Development of smart injection devices
    • Increasing demand for self-administration devices
  • Market Challenges
    • Low patient compliance of needles and lack of training in using injectable devices

Porter's Five Forces: A Strategic Tool for Navigating the Injectable Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Injectable Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Injectable Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Injectable Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Injectable Drug Delivery Market

A detailed market share analysis in the Injectable Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Injectable Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Injectable Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Injectable Drug Delivery Market

A strategic analysis of the Injectable Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injectable Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Antares Pharma by Halozyme Therapeutics, Becton, Dickinson and Company, Eli Lilly and Company, Emperra GmbH, Enable Injections LLC, F. Hoffman - La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PlC, Novo Nordisk A/S, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SiO2 Medical Products, Stevanato Group, Tandem Diabetes Care, West Pharmaceutical Services, Inc., and Wilhelm Haselmeier GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Injectable Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Conventional Injection Devices and Self-injection Devices. The Self-injection Devices is further studied across Autoinjectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors.
  • Based on Usability, market is studied across Disposable and Reusable.
  • Based on Therapeutic Application, market is studied across Autoimmune Diseases, Cancer, Chronic Diseases, Hormonal Therapies, and Infectious Diseases.
  • Based on End-user, market is studied across Home Care Settings and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Technological advancements in needle technology
      • 5.1.1.2. Increasing prevalence of chronic diseases
      • 5.1.1.3. Significant rise in elderly population worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High development costs of injectable drug delivery solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of smart injection devices
      • 5.1.3.2. Increasing demand for self-administration devices
    • 5.1.4. Challenges
      • 5.1.4.1. Low patient compliance of needles and lack of training in using injectable devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Increasing preference for self-injection devices due to ease of use
    • 5.2.2. End-user: Exploring applications in home care settings due to safety and portability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Injectable Drug Delivery Market, by Device Type

  • 6.1. Introduction
  • 6.2. Conventional Injection Devices
  • 6.3. Self-injection Devices
    • 6.3.1. Autoinjectors
    • 6.3.2. Needle-free Injectors
    • 6.3.3. Pen Injectors
    • 6.3.4. Wearable Injectors

7. Injectable Drug Delivery Market, by Usability

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Injectable Drug Delivery Market, by Therapeutic Application

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Chronic Diseases
  • 8.5. Hormonal Therapies
  • 8.6. Infectious Diseases

9. Injectable Drug Delivery Market, by End-user

  • 9.1. Introduction
  • 9.2. Home Care Settings
  • 9.3. Hospitals & Clinics

10. Americas Injectable Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Injectable Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Injectable Drug Delivery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Stevanato Group Launches Vertiva, An Innovative On-Body Drug Delivery System for Enhanced Patient Care and Sustainability
    • 13.3.2. Altaviz Introduces AltaVISC, A Revolutionary Auto-injector Platform Enhancing Drug Delivery Efficiency
    • 13.3.3. Launch of UDENYCA Autoinjector Enhances Patient Accessibility and Administration Efficiency
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Antares Pharma by Halozyme Therapeutics
  • 3. Becton, Dickinson and Company
  • 4. Eli Lilly and Company
  • 5. Emperra GmbH
  • 6. Enable Injections LLC
  • 7. F. Hoffman - La Roche Ltd.
  • 8. Insulet Corporation
  • 9. Johnson & Johnson Services, Inc.
  • 10. Medtronic PlC
  • 11. Novo Nordisk A/S
  • 12. Pfizer, Inc.
  • 13. Ravimed Sp. z o.o.
  • 14. Recipharm AB
  • 15. Sanofi S.A.
  • 16. SiO2 Medical Products
  • 17. Stevanato Group
  • 18. Tandem Diabetes Care
  • 19. West Pharmaceutical Services, Inc.
  • 20. Wilhelm Haselmeier GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. INJECTABLE DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. INJECTABLE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INJECTABLE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INJECTABLE DRUG DELIVERY MARKET DYNAMICS
  • TABLE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023